Drug class · Endocrine & metabolism
Insulins and insulin analogs Drug Codes & NDCs
Human insulin and modified insulin molecules (analogs), supplied in vials, cartridges and prefilled pens.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Kirstyinsulin aspart-xjhz | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Biocon Biologics Inc. | 83257-007 |
| Kirstyinsulin aspart-xjhz | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Biocon Biologics Inc. | 83257-008 |
| Langlarainsulin glargine-aldy | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Lanexa Biologics, LLC | 87682-090 |
| Lantusinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | sanofi-aventis U.S. LLC | 0088-2220 |
| Lantusinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-0876 |
| Lantus Solostarinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | sanofi-aventis U.S. LLC | 0088-2219 |
| Lantus Solostarinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-1398 |
| Lantus Solostarinsulin glargine | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-4068 |
| Levemirinsulin detemir | Insulin detemir 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-1276 |
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7726 |
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-7728 |
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-7433 |
| LYUMJEV Junior KwikPeninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8351 |
| LYUMJEV KwikPeninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8207 |
| LYUMJEV KwikPeninsulin lispro-aabc | Insulin lispro 200 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8228 |
| LYUMJEV Tempo Peninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8235 |
| Meriloginsulin aspart-szjj | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0024-5927 |
| Meriloginsulin aspart-szjj | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Sanofi-Aventis U.S. LLC | 0024-5928 |
| Myxredlininsulin human | Insulin human 1 [iU]/mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-0126 |
| Novolin 70/30human insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-1837 |
| Novolin 70/30human insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3007 |
| Novolin 70/30human insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-0403 |
| Novolin Nhuman insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-1834 |
| Novolin Nhuman insulin | Insulin human 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3004 |
| Novolin Rhuman insulin | Insulin human 100 [iU]/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-1833 |